Category Archives: Health

Setting Standards of Care for Brain Injuries in First Responders

COLUMBUS, Ohio, Apr 07: Management of sports-related concussions has come a long way in the past 25 years: Once considered a minor problem involving minimal time out of the game, a severe knock to the head is now assessed as a potential traumatic brain injury and, if confirmed, requires a structured recovery and an average wait of 13 days before play resumes. 

Many of the academic experts who have advanced the science behind concussions in student-athletes – and, in collaboration with the Department of Defense, in soldiers as well – are now focused on addressing these head injuries in a population that’s similar, but different: first responders. 

The considerations are many, spanning from a first responder’s potential sports or military injuries in a previous life to the factors that signal when it’s safe to return to duty after a strike to the head. Getting a clinical diagnosis is key to putting an injured first responder on the proper trajectory of recovery – not just working safely, but also maintaining a satisfying quality of life, experts agree. 

Researchers will soon publish the first evidence-based guidelines for traumatic brain injury (TBI) recognition and management and return to duty in first responders – a group encompassing law enforcement officers, corrections personnel, firefighters and emergency medical technicians (EMTs). 

The authors will be the nearly 60 experts who convened at The Ohio State University in late March to pursue consensus on protocols surrounding six frameworks: workplace policies, injury prevention measures, challenges of recognizing injuries, diagnosis and treatment of the injury, mental health monitoring, and steps needed to get a concussed first responder back to work. 

“This is a critical step in improving the care and support for our first responders who risk so much for us every day,” said Jaclyn Caccese, associate professor in the School of Health and Rehabilitation Sciences (HRS) at The Ohio State University. 

Caccese co-hosted the 1st International Conference on TBI in First Responders with James Oñate, interim director of HRS, interim vice dean for health and rehabilitation sciences in the College of Medicine, and a professor in the HRS Division of Athletic Training. 

One universally accepted fact drove the work: Brain health in first responders is a matter of public safety – for the injured personnel, their colleagues, their families and the public they are sworn to protect. 

After working together for several months in six workgroups, the scholars, clinicians and first responders met March 26-27 to share what they’ve learned and vote on a series of recommended guidelines. The final recommendations and consensus statement will be published early next year in the Journal of Head Trauma Rehabilitation. 

While head injury data on first responders is minimal, a meta-analysis of studies to date suggests that about 60% of law enforcement and corrections officers have suffered at least one traumatic brain injury in their lifetime, and 17% have experienced a TBI on the job. Among firefighters, lifetime TBI prevalence ranges from 62% to 77%. There have been no studies of head injuries in EMTs. 

Though what has been learned by studying sports and military concussions has given these teams a head start, most workgroups indicated that the need for more research specific to the first responder workforce is apparent. 

“We’ve lumped first responders together. We’re going to stop doing that,” Oñate said. “This is the beginning, and we’re starting with many things we’ve advanced already. We’re not starting from scratch.” 

In a first-of-its-kind survey of Ohio law enforcement officers in 2024, Caccese, Oñate and colleagues reported that 74% of officers had a lifetime history of one or more head injuries, and 30% had a head injury that happened on the job. Further analysis showed post-traumatic stress disorder and depressive symptoms were higher in those who had experienced one or more head injuries.  

At the conference, each of the six workgroups brought forward four to five recommendations for a vote. Consensus was reached on all but two, though many will undergo refinements before publication.

Overarching themes included standardizing methods of recognizing and treating TBIs and assessing return-to-duty readiness; ensuring no punitive actions are taken against an injured and recovering first responder; protecting the head as much as possible during training intended to expose new personnel to risks linked to blasts and being hit at work; and educating agencies, first responders, families and health care providers about TBI risks, prevalence and potential lasting effects when they’re not managed well. 

“Almost every workgroup talked about the importance of education,” Caccese said. 

The educational component is critical because this effort is still very new. Many agencies are unaware that an international effort is afoot to address TBI in first responders. In addition to publishing the conference outcomes in a scientific journal, the group plans to present at academic and first responder-specific conferences and approach publications targeted to first responder agencies. 

Conference attendees acknowledged TBI in this workforce is a delicate subject for so many reasons, not the least of which is the stigma linked to injuries that affect performance in a profession characterized by a mission-first mindset that leads to underreporting. First responders served on every workgroup alongside the academic researchers to help keep suggestions realistic for the workplace cultures and practices that are being asked to change.

The conference featured a panel discussion with three law enforcement officers who had received a head injury on the job. They described symptoms including double vision, dizziness, chronic migraines, short-term memory loss, speech problems and temporary paralysis, as well as complications navigating recovery – with one eventually losing her job as a result of her occupational injury. 

Hearing from these officers “helps give us context about the stakes to come up with recommendations for first responders to return to full capacity,” said Nathan Edwards, a research scientist in Ohio State’s Human Performance Collaborative.

Improving care for first responders isn’t stopping with the brain: Researchers are investigating musculoskeletal issues, physical performance and heart health in the first responder population as well, Oñate said. 

“It’s on us to get the level of evidence much higher,” he said. “It’s also on us to communicate with the first responder community to look at what impacts they’re looking for and what they need to have happen.” 

This work was supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the Traumatic Brain Injury and Psychological Health Research Program. The conference was also supported by HRS and Ohio State’s Center for Brain Injury Recovery & Discovery. 

 

AIIMS Delhi Introduces Virtual Reality Facility to Enhance Medical Training

All India Institute of Medical Sciences Delhi has introduced a state-of-the-art virtual reality (VR) training centre aimed at enhancing medical education and clinical training for students.

The new facility uses immersive VR technology to simulate real-life medical scenarios, allowing students to practice procedures and decision-making in a controlled, risk-free environment. This approach is expected to strengthen practical skills and improve confidence before handling actual patients.

According to institute officials, the initiative is part of a broader effort to integrate advanced technology into medical training and keep pace with global standards in healthcare education. The VR centre will support learning across multiple disciplines, offering interactive modules tailored to various medical specialties.

The launch marks a significant step toward modernizing medical education in India, providing students with innovative tools to gain hands-on experience and improve patient care outcomes.

Former Vice President Venkaiah Naidu to Inaugurate 10th Edition of CAHOCON 2026 in Chennai

Chennai, Apr 06: Shri M. Venkaiah Naidu, former Vice President of India, is set to inaugurate the 10th edition of CAHOCON 2026, India’s premier healthcare quality conference organized by the Consortium of Accredited Healthcare Organizations (CAHO), scheduled to be held in Chennai from April 10 to 12, 2026.

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals Group, will be the Guest of Honour at the inaugural session. Dr. C. Sylendra Babu, IPS (Retd.), former Director General of Police and Head of Police Force, Tamil Nadu, will be the Guest of Honour at the Graduation Ceremony. The event is expected to bring together around 2,500 healthcare leaders, clinicians, administrators, and policymakers, including over 200 international delegates, to deliberate on advancements in patient safety, healthcare quality, accreditation, and digital transformation. Ms. Mallika Srinivasan, Chairman & MD, TAFE will be the Chief Guest and Mr. Sunil Kumar Barnwal IAS, Additional Secretary and CEO, National Health Authority, Government of India will be the Guest of Honour at the valedictory ceremony.

Other dignitaries participating in CAHOCON 2026 include Dr. Vijay Agarwal, President; Dr. Lallu Joseph, Secretary General, Consortium of Accredited Healthcare Organizations, and AGS & Quality Manager at Christian Medical College Vellore; Dr. Nalla G Palaniswami, Organizing Chairperson CAHOCON 2026, and Chairman of Kovai Medical Centre and Hospital; Dr. S. Manivannan, Organizing Co-Chairperson, and Founder & Managing Director of Kauvery Group of Hospitals; Dr. Sathish Devadoss, Organizing Secretary, and Vice Chairman of Devadoss Multispecialty Hospitals; and Dr. Ilankumaran Kaliamoorthy, Academic Committee Member, CAHOCON 2026, and CEO of Apollo Hospitals Chennai.

Guided by the theme ‘Tech, Touch, Trust- The new Healthcare code.’, CAHOCON 2026 will emphasize the human connection, reliability, and innovation at the heart of advancing healthcare quality and patient safety. The main conference will feature high-impact scientific sessions, panel discussions, innovation showcases, and interactive networking opportunities, along with poster presentations by researchers and clinicians that highlight innovative projects and foster knowledge exchange.

Alongside the conference, CAHOCON 2026 will host a comprehensive healthcare exhibition with over 200 stalls, showcasing cutting-edge products and services from leading medical equipment manufacturers, digital health companies, pharmaceutical firms, and service providers. The conference will also feature four breakout houses, designed to facilitate smaller group discussions, interactive workshops, and focused learning sessions.

Recognized by the International Society for Quality in Health Care (ISQua) as the first ISQua Regional Conference for South Asia, CAHOCON 2026 will witness addresses by 20 ISQua experts. The conference will honour excellence in healthcare quality and patient safety through the prestigious CAHO Awards, celebrating institutions and professionals who have made outstanding contributions to advancing healthcare standards.

A key highlight of CAHOCON 2026 is the pre-conference workshops. Over 40 such workshops will be organized on April 10 engaging 32 leading hospitals from Chennai, providing hands-on training and practical insights into quality improvement and patient safety for the participants.

Over the past decade, CAHO has evolved into a powerful national movement dedicated to strengthening healthcare quality and patient safety across India. Through continuous training, accreditation support, knowledge-sharing platforms and collaborative initiatives, the organization is working to build a culture where quality and safety are embedded in every aspect of healthcare delivery.

CAHOCON is one of the most influential platforms for advancing healthcare quality and patient safety in India. This collaborative forum aims to strengthen a culture of continuous improvement in healthcare systems and ensure that patients across the country benefit from safer and higher-quality care.

New Reform Bill to Simplify Rules and Support Growth in Healthcare Sector

New Delhi: The Jan Vishwas Bill is expected to bring significant relief to India’s healthcare ecosystem by reducing regulatory pressure and encouraging smoother operations across the sector, according to the Ministry.

The Bill focuses on decriminalising minor offences and replacing them with civil penalties, a move that could greatly benefit hospitals, diagnostic centres, pharmaceutical firms, and medical device companies. Instead of facing criminal action for procedural lapses, healthcare providers will now be subject to warnings, improvement notices, or monetary penalties—making compliance less intimidating and more practical.

Pic Credit: Pexel

For the health sector, this shift is particularly important. Medical institutions often deal with complex regulations, and even small documentation errors could earlier lead to severe legal consequences. By removing the fear of criminal prosecution for such minor issues, the Bill allows healthcare professionals to focus more on patient care rather than legal risks.

The reform is also expected to boost investment and innovation. A more predictable and business-friendly regulatory environment can attract new players in areas like pharmaceuticals, medical technology, and health services. This could improve infrastructure, expand access to care, and support the growth of India’s healthcare industry.

Additionally, faster and more transparent compliance processes may improve service delivery. With fewer legal hurdles, approvals and operations can become more efficient, ultimately benefiting patients through better access and reduced delays.

Officials believe that the Bill will not only enhance ease of doing business but also strengthen the overall healthcare system by making it more responsive, efficient, and growth-oriented.

AACI Statement on Fiscal Year 2027 Budget Proposal

The Association of American Cancer Institutes (AACI) is disappointed in the Fiscal Year 2027 (FY 27) budget proposal released by President Donald J. Trump. Under the proposed budget, funding for the National Institutes of Health (NIH) would be cut by $5.787 billion, reducing the agency’s overall budget to $41.429 billion – 12.3 percent below the FY 26 total.

For decades, the NIH has funded breakthroughs that have led to effective treatments for cancers that were once fatal. Advances in immunotherapies and precision medicine have expanded the possibilities of customized cancer treatment. Early detection tools help diagnose cancer when it’s most treatable – and most affordable to treat. When funding is cut, promising science is shelved, clinical trials are halted, and patients lose access to the treatments that could save or extend their lives.

Further cuts to NIH funding would hinder the agency’s effectiveness and contradict the stated goals of its leadership. Dr. Jay Bhattacharya, who began his tenure as NIH director just over one year ago, has repeatedly stressed the importance of engendering trust and restoring confidence in scientific research among the American people. Stable, predictable funding increases bolster the research infrastructure that is essential to building trust and accelerating progress against cancer and other devastating diseases.

AACI deeply appreciates the ongoing efforts of members of Congress—on both sides of the aisle—who have demonstrated their commitment to protecting funding for the NIH. We urge Congress to continue its longstanding bipartisan support of biomedical research and reject the FY 27 budget proposal. AACI is eager to collaborate with our champions in Congress, NIH leadership, and the Trump administration to ensure that scientists can conduct lifesaving research without disruption and that the NIH will remain a world leader in biomedical research.

Canopy Surpasses 350,000 Lives Protected; Expands Clinical Strategy Team to Accelerate Pre-Escalation Intervention

SAN FRANCISCO, CA – Apr 1 – Canopy, the category leader in connected safety platforms for U.S. health systems, announced that it now protects more than 350,000 lives nationwide and has expanded itsClinical Strategy Team to further the shift from reactive incident response to proactive, pre-escalation prevention with rich clinical focus and experience.

As workplace violence, nurse burnout, and staff turnover continue to strain hospital margins, Canopy is investing in deep clinical expertise to provide health systems with the strategies and tools needed for safer daily operations. The expansion includes the addition of Dr. Ryan Oglesby, PhD, MHA, RN, CEN, CFRN, NEA-BC, 2025 National Emergency Nurses Association (ENA) and this year’s Past President, as a Clinical Strategy Director. He joins current Clinical Strategy Director Jeanne Venella, DNP, MS, CEN, CPEN, a nationally recognized expert in clinical operations and patient safety. Together, they strengthen Canopy’s ability to partner directly with executive and nurse leaders on large-scale safety initiatives.

“At Canopy, we’re turning the commitment to nurse safety into real-world, real-time activation so that bedside caregivers can get help the moment they need it,” said Ryan Oglesby, Clinical Strategy Director. “By growing this clinical strategy team, we are bridging the gap between frontline caregivers and hospital leadership to ensure the protections necessary to keep clinicians focused on taking care of patients.”

The company’s rapid growth, fueled by its expanding team and recent Series B funding, reflects rising demand from health system leaders who recognize that safety is a critical driver of patient outcomes. Workplace violence drives turnover, increases labor costs, and disrupts productivity. To address these challenges, Canopy is accelerating the evolution of its Connected Safety Platform.

Over the past six months, Canopy has introduced enhanced mobile responder capabilities across Android and iOS, as well as integrations with Epic, Vocera, and TigerConnect, providing security and clinical teams with immediate, high-fidelity location data. Coupled with advanced reporting and real-time analytics, these updates empower leadership to identify high-risk areas and optimize response protocols.

In their recent Healthcare Safety Report, which surveyed over 1,000 healthcare workers and leaders, Canopy found that nearly 85% of respondents have experienced at least one workplace violence event in their careers. The report also highlighted a direct link to turnover, with over one-third of workers considering leaving their positions due to safety issues.

“Our mission is to safeguard healthcare workers wherever they occur across the campus—from the parking garage to the exam room,” said Jeanne Venella, Clinical Strategy Director. “As hospitals move beyond simply reacting to incidents, we are providing the infrastructure for a prevention-first model that strengthens both staff well-being and overall operations.” At the last ENA conference I attended, a nurse approached me in our exhibit hall and stated, “My Canopy button saved my life last week!” Emergency Department Nurse at TJU.

Canopy’s platform is actively trusted by leading organizations, including the University of Michigan Health-Sparrow and ECU Health. The company will continue expanding its Clinical Strategy Team as part of its long-term commitment to helping health systems protect their people and performance.

“We knew we couldn’t eliminate workplace violence entirely, but we could certainly prevent the harm coming to our team members. We wanted them to feel empowered, not monitored. Once we rolled [Canopy’s platform] out, you could feel the shift—they finally felt safer.” Chris Nemets, Regional CNIO, University of Michigan Health, states about incorporating Canopy into Michigan Health’s system.

India’s Bioeconomy Enters High-Growth Phase, Eyes $200 Billion Milestone

Pic Credit: Pexel

India’s bioeconomy is fast emerging as one of the country’s most dynamic growth engines, steadily approaching the $200 billion mark. Fueled by innovation, research, and a thriving startup ecosystem, the sector is redefining how science contributes to economic progress and everyday life.

From Niche to Mainstream

Once limited to specialized research and pharmaceuticals, the bioeconomy has expanded into a wide spectrum of industries, including healthcare, agriculture, biofuels, and environmental solutions. This transformation reflects India’s ability to combine scientific expertise with real-world applications, creating solutions that are both scalable and impactful.

Innovation Driving the Momentum

At the heart of this growth lies a strong push for innovation. Startups, research institutions, and established companies are working together to develop next-generation technologies in areas such as biotechnology, genomics, and sustainable agriculture.

Supportive government policies and increased funding have further accelerated this momentum, enabling new ideas to move from laboratories to markets more quickly than ever before.

Beyond Growth: A Broader Impact

The rise of the bioeconomy is not just an economic story—it is also about addressing critical challenges. From improving healthcare access to developing climate-resilient crops and clean energy alternatives, the sector is playing a key role in shaping a more sustainable future.

It is also creating skilled jobs, attracting global investments, and strengthening India’s position as a hub for affordable and innovative solutions.

Looking Ahead

As the bioeconomy edges closer to the $200 billion milestone, the focus is shifting toward scaling innovation and deepening collaboration between industry and academia. Strengthening infrastructure and nurturing talent will be crucial to sustaining this growth.

With strong foundations and growing global relevance, India’s bioeconomy is entering a new phase—one defined by innovation, resilience, and the potential to make a lasting impact on both the economy and society.

Childhood cancer is a substantial contributor to global childhood mortality and global cancer burden

Seattle, Apr 03: A new study published in The Lancet highlights that childhood cancer remains the eighth-leading cause of death among children globally, with outcomes heavily influenced by access to healthcare resources.

The findings, part of the Global Burden of Disease (GBD) 2023 study, were led by researchers from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine and St. Jude Children’s Research Hospital. The study estimates that in 2023, there were approximately 377,000 new cases of childhood cancer worldwide, resulting in 144,000 deaths.

While global childhood cancer mortality has declined by 27% since 1990, the burden remains disproportionately high in low- and middle-income countries (LMICs). These regions accounted for 85% of new cases, 94% of deaths, and 94% of disability-adjusted life years (DALYs) in 2023, underscoring stark global inequities.

“While outcomes for many childhood cancers have improved in high-income countries, these gains have not been equitably shared,” said Lisa Force, lead author from IHME. “Delays in diagnosis, limited access to treatment, and systemic healthcare challenges continue to drive disparities in LMICs.”

Urgent Need for Investment in Cancer Care Systems

The study emphasizes that improving survival rates will require significant investment in cancer control systems, particularly in LMICs. Key priorities include:

• Strengthening referral systems for early diagnosis
• Expanding access to chemotherapy, surgery, and radiotherapy
• Enhancing workforce training
• Improving cancer registries and surveillance systems

Regions such as the WHO African and Western Pacific regions reported the highest number of cases, with the WHO African Region experiencing the greatest mortality rates. Notably, deaths in the African region have increased by nearly 56% since 1990.

Most Common Childhood Cancers

The study identified the most burdensome childhood cancers globally as:

• Leukemia
• Brain and central nervous system cancers
• Non-Hodgkin lymphoma

Nearly half of all childhood cancer deaths in 2023 were linked to six key cancers identified under the World Health Organization’s Global Initiative for Childhood Cancer (GICC).

Global Efforts to Improve Survival Rates

World Health Organization (WHO), in partnership with St. Jude Children’s Research Hospital, continues to advance global initiatives aimed at improving childhood cancer survival rates to at least 60% by 2030.

“These data provide a critical tool to monitor progress and evaluate the global effort to reduce childhood cancer deaths,” said Nickhill Bhakta, senior author and director at St. Jude Global. “Our mission is to ensure equitable access to life-saving care for children worldwide.”

The study underscores the urgent need for coordinated global action to address disparities in childhood cancer outcomes and ensure that advancements in treatment benefit children everywhere, regardless of geography or economic status.

Autism Awareness Day: Dr. Ketan Patel Stresses Diet & Exercise Benefits

Apr 1: On the eve of World Autism Awareness Day (April 2,2026)  Dr Ketan Patel of Specialty Homeopathy said that 80 percent of autism cases can be cured through diet and exercise and in 20 percent of children, medicines are also required along with diet due to metabolic and genetic reasons.

Homeopathy has proven to be very effective in treating in such genetic, metabolic & mitochondrial autism (Syndromic AUTISM). Genetic effects can be largely eliminated or controlled through homeopathic medicines.

Dr Ketan Patel said that the effects of genes affecting sodium channel, potassium channel, aqua channel, epileptic, Encephalopathy, intellectual and other protein disruption can be eliminated up to 90 percent with homeopathic medicines along with diet and exercise. The research of these experts has found that only 10 percent of genes cannot be improved.

Dr Ketan Patel further said that “The protocols for autism treatment of Western countries do not show the effect of treatment in a certain time. There is a shortage of doctors trained to treat autism in India. Therefore, it is necessary for us to improve the protocols of Western countries and formulate our own new protocols. Indian doctors are far ahead in the treatment of autism, compared to Western countries. Therefore, it is necessary for us to implement a new protocol with diet, exercise and individual treatment plan in the treatment of autism.”

Dr Jayesh Sheth said that autism is a type of disease in which children are not mentally retarded, but due to some obstruction or disturbance in the wiring of neurons in their brain, their ability to speak and think is affected. Such a gene problem is found in 50 percent of autism cases. The earlier such children are diagnosed, the more effective the treatment and guidance is.

Dr Patel and Dr Sheth further said that currently, doctors are providing up to Rs. 5,00,000 annually for the treatment, genetic testing and related therapy of more than 100 needy children suffering from autism. In the coming time, doctors from all branches like Allopathic, Homeopathic, Ayurvedic, who are doing treatment and research in the field of autism in Gujarat, are committed to jointly work with the therapists and bring about rapid treatment and improvement.

1 in every 36 children born worldwide is affected by autism. This figure is considered extremely alarming, as the number of children suffering from autism is higher than the percentage of children suffering from life-threatening diseases such as cancer, diabetes and HIV worldwide.

What is autism?

It is a disease affecting the neurological, endocrinal, and gastrointestinal systems, diagnosed in children between the ages of 18 and 24 months and its symptoms are as follows.

– The child does not speak on time or does not speak at all cannot use sentences after speaking a few words.

– Does not make eye contact with family members such as mother, father, brother, sister.

– Does not play with children of the same age group when they are playing and prefers to go away and play alone.

– Laughs and cries for no reason.

– Plays with a toy, object or piece of clothing for a long time, sleeps with it.

– Wiggles fingers, jumps, keeps moving around in one place.

– Holds hands over ears in fear of the sound of mixers, vacuum cleaners, firecrackers.

– Throws things and screams.

– Hurts body with teeth, hits head against wall.

It is advisable that if two or more of the above symptoms are observed in a child take your child to a doctor to get diagnosed with autism and get proper treatment. The earlier your child is diagnosed with autism or a similar condition, the greater the child’s chances of recovering from these symptoms.

– Scientists, doctors, universities, pharmaceutical and diagnostic companies around the world are working to diagnose autism more quickly.

In order to make people aware of this disease, the World Health Organization (WHO) has declared April 2 as World Autism Awareness Day every year and the entire month of April as Autism Awareness Month to spread awareness and information about autism. During this month, famous places around the world are decorated with blue lights. Such as Sydney Opera – Australia, Burj Khalifa – Dubai, Leaning Tower – Italy, London Bridge – UK, Pyramids of Giza – Egypt, Eiffel Tower – France (Paris) are decorated with blue lights.

Diagnosis of autism

This disease, which is seen in children from the age of 18 months to 30 months, cannot be detected by any single test or other medical report such as CT SCAN, MRI SCAN, PET SCAN or EEG so apart from the above report the diagnosis can be made in the following two stages.

In the first stage, to know whether the physical and mental development of the children is happening according to their age or not, the child’s learning ability, his way of speaking, words and sentences along with his facial expressions are studied and recorded and the development rate of the children (Physical & Mental Development) is kept in mind at a certain time interval such as 12 months, 18 months or 24 months i.e. at the age of 2 years. In this above study, the diagnosis is made on the basis of the answers of scientifically prepared questionnaires to the child’s parents, his doctors and the child’s caregivers.

The second stage is diagnosed by doctors who specialize in this disease such as a Developmental Paediatrician, Child Neurologist, Child Psychiatrist/Psychologist (specialist in child neurology and behavioural disorders), and DAN (Defeat Autism Now) doctors.

Causes of autism spectrum disorder

Doctors and scientists around the world are trying to find out the causes of this disease but have not been able to come up with a specific cause. However based on the medical history records of old cases/new cases and the similarities and differences in them, they have come to the following conclusions.

– Chronic infection in the mother’s body that affects the mental development of the child during pregnancy, such as Torch Infection.

– Hormonal imbalance due to the endocrine gland in the mother, thyroid deficiency.

– Pollution in the atmosphere, pollution in drinking water

Genetic disorder

– Tuberculosis disease in family members

– Epilepsy & Seizure Disorder

– Serotonin and neurotransmitter related disease

Many children develop autism after receiving the MMR vaccine, and doctors around the world have differing opinions on the matter. According to the CDC USA (CDC – Centre for Disease Control & Prevention), 1 in 31 children born worldwide are affected by autism, and this figure is considered alarming, as it is more than the combined incidence of cancer, diabetes, and HIV.

Treatment

Both Doctors have 35 Years of experience: Dr Ketan Patel is in Treatment Part And Dr Jayesh Sheth In Genetic Metabolic & Mitochondrial Diagnostic Part

Lifestyle also influences the severity of endometriosis symptoms